Comparison of the colorimetric microdilution-based commercial MICRONAUT-AM test with the conventional broth microdilution test in assessing antifungal susceptibility of multidrug-resistant Candidozyma (Candida) auris

Aims: Candidozyma (Candida) auris is a pathogen that causes invasive infections and develops multidrug resistance. Antifungal susceptibility testing is vital for therapeutic management. In this context, this study was conducted to compare the efficacies of the commercial MICRONAUT-AM test (MN) and the conventional broth microdilution test (BMD) in assessing antifungal susceptibility of C. auris isolates. Methods: The material of this comparative study consisted of 116 C. auris strains isolated between February 2024 and April 2024. The efficacies of MN and BMD in assessing the susceptibility of C. auris isolates to antifungal agents, including fluconazole, amphotericin B, micafungin, and anidulafungin, were compared. To this end, the agreement and essential agreement between the two tests and minor, major, and very major error rates were calculated. Results: The agreement between the two tests was found to be high (98.3%) in assessing the susceptibility of C. auris isolates to micafungin and anidulafungin agents but low in assessing their susceptibility to fluconazole and amphotericin B agents. C. auris isolates were found to be 66.4% resistant to fluconazole with BMD and 94.8% resistant with MN, while they were found to be 44% resistant to amphotericin B with BMD and not resistant with MN. Compared to the reference method BMD, the MN detected the resistance of C. auris isolates against micafungin and anidulafungin agents with high accuracy but could not accurately detect their resistance against fluconazole and amphotericin B agents. Conclusion: Our findings suggest that the commercial test kit evaluated in this study may require optimization with respect to the antifungal agents it includes. Confirmation of these results through comparative studies involving different commercial kits is necessary to determine whether similar findings can be observed.

Authors

Institutions

Publication Details

Journal
DergiPark (Istanbul University)
Published
2025-12-19
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of the colorimetric microdilution-based commercial MICRONAUT-AM test with the conventional broth microdilution test in assessing antifungal susceptibility of multidrug-resistant Candidozyma (Candida) auris

Sebahat Aksaray, Deniz Turan
DergiPark (Istanbul University)
Antifungal resistance and susceptibility
article

Comparison of the colorimetric microdilution-based commercial MICRONAUT-AM test with the conventional broth microdilution test in assessing antifungal susceptibility of multidrug-resistant Candidozyma (Candida) auris

Sebahat Aksaray, Deniz Turan
article en

Abstract

Aims: Candidozyma (Candida) auris is a pathogen that causes invasive infections and develops multidrug resistance. Antifungal susceptibility testing is vital for therapeutic management. In this context, this study was conducted to compare the efficacies of the commercial MICRONAUT-AM test (MN) and the conventional broth microdilution test (BMD) in assessing antifungal susceptibility of C. auris isolates. Methods: The material of this comparative study consisted of 116 C. auris strains isolated between February 2024 and April 2024. The efficacies of MN and BMD in assessing the susceptibility of C. auris isolates to antifungal agents, including fluconazole, amphotericin B, micafungin, and anidulafungin, were compared. To this end, the agreement and essential agreement between the two tests and minor, major, and very major error rates were calculated. Results: The agreement between the two tests was found to be high (98.3%) in assessing the susceptibility of C. auris isolates to micafungin and anidulafungin agents but low in assessing their susceptibility to fluconazole and amphotericin B agents. C. auris isolates were found to be 66.4% resistant to fluconazole with BMD and 94.8% resistant with MN, while they were found to be 44% resistant to amphotericin B with BMD and not resistant with MN. Compared to the reference method BMD, the MN detected the resistance of C. auris isolates against micafungin and anidulafungin agents with high accuracy but could not accurately detect their resistance against fluconazole and amphotericin B agents. Conclusion: Our findings suggest that the commercial test kit evaluated in this study may require optimization with respect to the antifungal agents it includes. Confirmation of these results through comparative studies involving different commercial kits is necessary to determine whether similar findings can be observed.

DergiPark (Istanbul University)
Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR)
Openalex Percentile: Top 26%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparison of the colorimetric microdilution-based commercial MICRONAUT-AM test with the conventional broth microdilution test in assessing antifungal susceptibility of multidrug-resistant Candidozyma (Candida) auris — Sebahat Aksaray, Deniz Turan · DergiPark (Istanbul University) (2025) | TGRS Research Map | TGRS